Danaher (DHR) DIvidends Date & History

Key Takeaways

• Danaher Corporation pays a quarterly dividend of $0.40 per share, for an annualized total of $1.60 and a current yield of approximately 0.76%.
• The dividend has grown steadily, with recent increases and a multi-year track record of annual raises.
• Payout ratio remains low at roughly 18-27%, supported by strong free cash flow coverage.
• Payments have been consistent since 1993, positioning DHR as a dividend growth stock rather than a high-yield name.
• Yield is modest compared to some healthcare peers but offers sustainability and growth potential for long-term investors.

Dividend Overview

Danaher Corporation maintains a conservative dividend policy focused on steady growth and financial flexibility. The company pays dividends quarterly, with the most recent declaration setting the quarterly amount at $0.40 per share. This results in an annualized dividend of $1.60 and a trailing yield near 0.76% based on recent share prices around $210-$212. DHR is best characterized as a dividend growth stock with a modest yield, emphasizing consistent increases over high current income. The policy aligns with its life sciences and diagnostics operations, where reinvestment supports long-term expansion while returning capital to shareholders.

Dividend History and Growth

Danaher has paid dividends since 1993 and has delivered consistent quarterly distributions without interruption. Annualized payouts have risen over time, with the current $1.60 level reflecting multiple increases, including a recent step-up to $0.40 quarterly. Growth rates include double-digit compound annual growth over five years in several analyses, supported by eight or more consecutive years of raises in recent periods. The company has avoided cuts, maintaining a reliable profile through economic cycles and strategic shifts such as portfolio adjustments.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable. Payout ratios range from approximately 18% to 27% of earnings, well below typical thresholds for concern and indicating ample coverage. Free cash flow provides strong backing, with recent trailing twelve-month free cash flow exceeding $5 billion and supporting dividend and reinvestment needs. Low leverage and solid balance sheet metrics further enhance resilience. No near-term risks to the payout are evident, allowing room for future growth aligned with earnings expansion.

Dividend Compared to Industry Peers

Within the healthcare and life sciences sector, DHR yield of roughly 0.76% sits below peers such as Honeywell International at 3.76% or 3M at 1.83%, yet exceeds lower-yielding names like Thermo Fisher Scientific at 0.3%. Its payout ratio is among the more conservative, offering greater headroom for increases compared to higher-ratio peers. This profile suits investors prioritizing growth over immediate income relative to broader sector averages.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.

Is This Stock Attractive for Dividend Investors?

DHR may appeal to dividend growth investors seeking consistent annual increases and a low payout ratio that supports future raises. Its modest yield makes it less suitable for income-focused investors prioritizing high current distributions, but attractive for long-term holders who value sustainability and capital appreciation potential alongside dividends. Conservative investors may appreciate the strong free cash flow coverage and long payment history, while those seeking higher yields might look elsewhere in the sector. The stock suits portfolios emphasizing quality growth over immediate income generation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations